Filing Details

Accession Number:
0001209191-18-047536
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-08-17 19:57:41
Reporting Period:
2018-08-15
Accepted Time:
2018-08-17 19:57:41
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
353569 Quidel Corp QDEL In Vitro & In Vivo Diagnostic Substances (2835) 942573850
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1298084 D Thomas Brown 29890 Tanya Trail
Libertyville IL 60048
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-08-15 7,800 $14.43 61,758 No 4 M Direct
Common Stock Acquisiton 2018-08-15 7,800 $15.73 69,558 No 4 M Direct
Common Stock Disposition 2018-08-15 15,600 $70.12 53,958 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Options Disposition 2018-08-15 7,800 $0.00 7,800 $14.43
Common Stock Non-Qualified Stock Options Disposition 2018-08-15 7,800 $0.00 7,800 $15.73
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2012-05-10 2021-05-10 No 4 M Direct
0 2013-05-15 2022-05-15 No 4 M Direct
Footnotes
  1. The weighted average sale price for these transactions was $70.12 per share, with a range of $69.94 to $70.36. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares sold at each separate price.